BREAKING NEWS: FDA Approves Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer (read more here).
Go here to learn more or to get a mailed copy.
Home » Bio
Development of 89Zr-5A10, a novel radiotracer to..
David Ulmert, MD, PhD:
Memorial Sloan-Kettering Cancer Center
Jason Lewis, PhD
View All Board Members here.
Realm IDx, Inc.